Loss of HMGCS2 Enhances Lipogenesis and Attenuates the Protective Effect of the Ketogenic Diet in Liver Cancer
Hepatocellular carcinoma (HCC) is the most common primary malignant liver tumor with limited treatment. The ketogenic diet (KD) emerged as a metabolic therapy for cancer; however, the antitumor effect on HCC remains controversial. We previously reported that the ketogenesis rate-limiting enzyme, 3-h...
Main Authors: | Yuan-Hsi Wang, Fat-Moon Suk, Yi-Jen Liao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/7/1797 |
Similar Items
-
LONP1 targets HMGCS2 to protect mitochondrial function and attenuate chronic kidney disease
by: Mi Bai, et al.
Published: (2023-02-01) -
Regulation of Ketogenic Enzyme HMGCS2 by Wnt/β-catenin/PPARγ Pathway in Intestinal Cells
by: Ji Tae Kim, et al.
Published: (2019-09-01) -
Ligustilide covalently binds to Cys129 of HMGCS1 to ameliorate dyslipidemia
by: Kaixue Zhang, et al.
Published: (2023-10-01) -
Liver-Derived Exosomes Induce Inflammation and Lipogenesis in Mice Fed High-Energy Diets
by: Jihee Lee, et al.
Published: (2022-12-01) -
Ketogenic diet in pediatric patients with epilepsy
by: Bartłomiej Pawlicki, et al.
Published: (2019-07-01)